期刊文献+

老年女性2型糖尿病患者骨量变化与骨代谢生化指标的观察分析 被引量:3

The investigation and analysis of bone mineral density and bone metabolic markers in elderly females with type 2 diabetes mellitus
暂未订购
导出
摘要 目的研究老年女性2型糖尿病患者骨量及骨代谢生化指标的变化。方法运用QCT测定42例正常老年女性以及31例确诊为2型糖尿病的老年女性患者的腰椎松质骨密度,检测糖化血红蛋白(糖尿病组)、胰岛素及C肽(空腹及餐后2h)、性激素、血钙、磷、总碱性磷酸酶、骨钙素及尿脱氧吡啶啉、尿钙、磷。结果①老年女性2型糖尿病组骨密度与年龄相匹配的对照组比较无显著差异(P>0.05);②老年女性糖尿病组Dpd及BGP水平均高于对照组(P<0.05),而雌二醇水平低于对照组(P<0.05)。结论老年女性2型糖尿病患者与正常老年女性相比骨密度无明显差异;血BGP及尿Dpd是老年女性2型糖尿病患者骨代谢紊乱的敏感指标。 Objective To study the changes of bone mineral density and bone metabolic marker in elderly females with type 2 diabetes mcllitus. Methods The trabecular bone mineral density of the lumbar spines in 42 elder female controls and 31 elder females with type 2 diabetes mellitus was measured using QCT. Hemoglobin Alc (HbAlc) in type 2 diabetes mellitus patients, insulin (Ins) and C-peptide ( CP, fasting and 2h after meals), sex hormone, serum calcium (Ca) and phosphorus (P), alkaline phosphatase ( ALP), bone gla protein ( BGP), D-Pyridnoline ( Dpd), urinary calcium (UCa) and phosphorus (UP) were measured. Results 1 ) No significant difference of BMD was found between elderly females with type 2 diabetes mellitus and age-matched controls ( P 〉 0.05). 2) The levels of Dpd and BGP in elderly females with type 2 diabetes mellitus were higher than those of controls ( P 〈 0. 05) , but the estrogen level was lower (P 〈 0.05). Conclusion No significant difference of BMD was found between elderly females with type 2 diabetes mellitus and normal elderly women. Serum BGP and urinary Dpd are sensitive markers of the bone metabolic disorders.
出处 《中国骨质疏松杂志》 CAS CSCD 2011年第10期860-862,878,共4页 Chinese Journal of Osteoporosis
关键词 老年女性 2型糖尿病 骨密度 骨代谢生化指标 Elderly female Type 2 diabetes mellitus Bone mineral density Bone metabolic markers
  • 相关文献

参考文献13

二级参考文献48

共引文献201

同被引文献34

  • 1赵志明,汪福良,杨晓英,蒋志斌,唐世琪.老年男性血清睾酮水平变化与骨代谢生化指标的关系[J].中国临床保健杂志,2007,10(6):571-572. 被引量:5
  • 2Halbreich U, Kinon B J, Gilmore JA, et al. Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects. Psychoneuroendocrinology, 2003,28 ( Suppl 1 ) : 53-67.
  • 3Bergemann N, Parzer PC, Auler B. High bone turnover but normal bone mineral density in women suffering from schizophrenia. Psychological Medicine, 2008, 38 ( 8 ) : 1195- 1201.
  • 4Liang Y, Su YA, Zhao ZG, et al. Acute effects of haloperidol, amisulpride, and quetiapine on bone turnover markers in patients with schizophrenia. Journal of Clinical Psyehopharmacology, 2015,35 (5) :583-586.
  • 5Doknic M, Maric NP, Britvic D, et al. Bone remodeling, bone mass and weight gain in patients with stabilized schizophrenia in real-life conditions treated with long-acting injectable risperidone. Neuroendocrinology ,2011,94 ( 3 ) :246-254.
  • 6Bishop JR, Rubin LH, Reilly JL, et al. Rispefidone-associated prolactin elevation and markers of bone turnover during acute treatment. Ther Adv Psyehopbarmacol, 2012, 8(6) : A206.
  • 7Tintut Y, Morony S, Demer LL. Hyperlipidemia promotes osteoclastic potential of bone marrow cells ex vivo. Arterioscler Thromb Vasc Bio1,2004,24 (2) :6-10.
  • 8Takafumi M, Akira S, Yasato K, et al. Increased Bone Turnover in Patients with Hypereholesterolemia. Endoerinologia Japonica, 2008,55(1 ) :143-151.
  • 9Starup-Linde J, Eriksen SA, Lykkeboe S, et al. Biochemical markers of bone turnover in diabetes patients-a meta-analysis, and a methodological study on the effects of glucose on bone markers. Osteoporosis International, 2014, 25 ( 6 ) : 1697-1708.
  • 10马欢.胰岛素受体底物1通过P13K/Akt通路下调大鼠成骨细胞NFκB和BAX表达促进成骨细胞增殖.石家庄:河北医科大学,2014.

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部